OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From target discovery to clinical drug development with human genetics
Katerina Trajanoska, Claude Bhérer, Daniel Taliun, et al.
Nature (2023) Vol. 620, Iss. 7975, pp. 737-745
Closed Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Refining the impact of genetic evidence on clinical success
Eric Vallabh Minikel, Jeffery L. Painter, Coco Chengliang Dong, et al.
Nature (2024) Vol. 629, Iss. 8012, pp. 624-629
Open Access | Times Cited: 72

RNAi-based drug design: considerations and future directions
Qi Tang, Anastasia Khvorova
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 5, pp. 341-364
Open Access | Times Cited: 63

Genetic and molecular architecture of complex traits
Tuuli Lappalainen, Yang Li, Sohini Ramachandran, et al.
Cell (2024) Vol. 187, Iss. 5, pp. 1059-1075
Open Access | Times Cited: 17

A DNA language model based on multispecies alignment predicts the effects of genome-wide variants
Gonzalo Benegas, Carlos Albors, Alan J. Aw, et al.
Nature Biotechnology (2025)
Closed Access | Times Cited: 2

Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction
Danielle Rasooly, Claudia Giambartolomei, Gina M. Peloso, et al.
Nature Cardiovascular Research (2025)
Closed Access | Times Cited: 1

Refining the impact of genetic evidence on clinical success
Eric Vallabh Minikel, Jeffery L. Painter, Coco Chengliang Dong, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 22

Genetic factors associated with reasons for clinical trial stoppage
Olesya Razuvayevskaya, Irene Lopez, Ian Dunham, et al.
Nature Genetics (2024) Vol. 56, Iss. 9, pp. 1862-1867
Open Access | Times Cited: 8

Drug-target Mendelian randomization analysis supports lowering plasma ANGPTL3, ANGPTL4, and APOC3 levels as strategies for reducing cardiovascular disease risk
Fredrik Landfors, Peter Henneman, Elin Chorell, et al.
European Heart Journal Open (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 6

Drug development advances in human genetics‐based targets
X. Zhang, Wenjun Yu, Yan Li, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 5

CAR-T therapy and targeted treatments: Emerging combination strategies in solid tumors
Jiahao Liu, Xiaofei Jiao, Ding Ma, et al.
Med (2024) Vol. 5, Iss. 6, pp. 530-549
Closed Access | Times Cited: 5

Promising But Not Yet the Promised Land
Daphne T. Hsu
JACC Basic to Translational Science (2025)
Open Access

Unraveling Mechanisms of Genetic Risks in Metabolic Dysfunction–Associated Steatotic Liver Diseases: A Pathway to Precision Medicine
Xiang Zhang, Kyong‐Mi Chang, Jun Yu, et al.
Annual Review of Pathology Mechanisms of Disease (2025) Vol. 20, Iss. 1, pp. 375-403
Closed Access

A replication study of novel fetal hemoglobin-associated genetic variants in sickle cell disease-only cohorts
Yann Ilboudo, Nicolas Brosseau, Ken Sin Lo, et al.
Human Molecular Genetics (2025)
Closed Access

Discovery of drug targets for heart failure with preserved and reduced ejection fraction
Scott C. Ritchie
Nature Cardiovascular Research (2025)
Closed Access

A novel chemical property-based, alignment-free scalable feature extraction method for genomic data clustering
Rajesh Dwivedi, Aruna Tiwari, Neha Bharill, et al.
Computers & Electrical Engineering (2025) Vol. 123, pp. 110175-110175
Closed Access

Leveraging drug-target Mendelian randomization for tailored lipoprotein-lipid lowering
Éloi Gagnon, Benoît J. Arsenault
Current Opinion in Lipidology (2025)
Closed Access

Genetics of psoriasis spectrum disease – Advances in Targeted Therapeutics meeting
Anne Barton
Seminars in Arthritis and Rheumatism (2025), pp. 152665-152665
Open Access

Genetic Insights Into Hemorrhagic Stroke and Vascular Malformations: Pathogenesis and Emerging Therapeutic Strategies
Pazhanichamy Kalailingam, Kristiina Rannikmäe, Moran Hausman‐Kedem, et al.
Stroke (2025)
Closed Access

Page 1 - Next Page

Scroll to top